Home | Articles
Published on:November 2020
Indian Journal of Pharmaceutical Education and Research, 2020; 54(4):xx-xx
Original Article | doi:10.5530/ijper.54.4.x

Paralleling the Quality and Economy of Levofloxacin Hemihydrate and Cefuroxime Axetil Tablets


Authors and affiliation (s):

Atmaram Pawar1*, Mahesh Chainpure2, Vividha Dhapte-Pawar1

1Department of Pharmaceutics, Poona College of Pharmacy, Bharati Vidyapeeth University, Erandwane, Pune, Maharashtra, INDIA.

2Department of Drug Regulatory Affairs, Poona College of Pharmacy, Bharati Vidyapeeth University, Erandwane, Pune, Maharashtra, INDIA.

Abstract:

Aim/Background: The Government of India has initiated different regulations and provisions to provide low cost medicines at affordable rates than the high cost medicines. The government has initiated Jan Aushadhi stores in every city and village of India with the motto of promoting quality medicines for all at economic price. Improving the public perception and addressing their doubts regarding the quality and efficacy of low-cost medicines is a big challenge in this endeavour. Materials and Methods: In the present study, we have compared the low, medium and high cost medicines of biopharmaceutical classification system class I drug, levofloxacin hemihydrate and biopharmaceutical classification system class II drug, cefuroxime axetil, in order to verify their quality and efficacy. Existing low cost and medium cost brands of these drugs were selected and compared with their respective high cost products as per quality standards of Indian Pharmacopoeia viz. weight variation, friability, disintegration, assay and in vitro dissolution study specified in general and individual monographs. Moreover, ex vivo permeability and antimicrobial activities were assessed while comparing the efficacy of these products. Results: Findings from these studies revealed no significant differences between the efficacy of low cost, medium cost and high cost products. All products complied with the Indian Pharmacopoeia tests along with the comparable ex vivo permeation and antimicrobial activities for both the drugs. Conclusion: This study revealed that the low cost and medium cost tablets of levofloxacin hemihydrate and cefuroxime axetil can be used at par with the costlier tablets of same drugs.

Key words: Levofloxacin hemihydrate, Cefuroxime axetil, Generic, Microbial assay, Pharmacopoeial evaluation.

 




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the 2019 Release of Journal Citation Reports (source: 2018 Web of Science Data).

 

Impact Factor® as reported in the 2018 Journal Citation Reports® (Clarivate Analytics, 2019): 0.425

User login

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs